The event brings together organisations, practitioners and communities to reaffirm the foundations of harm reduction in the face of stigma and misinformation.
Ten years after the 2016 UNGASS, punitive drug policies remain dominant globally, with human rights violations, rising deaths and shrinking civic space undermining promises of reform.
The VNGOC invites civil society representatives to an informal online meeting to share updates and practical information about the SEssion, including modalities for NGO participation and key civil society activities.
The webinar will discuss the key issues that are likely to structure the debates, including in relation to tabled resolutions, and present how IDPC member organisations have used this forum for their advocacy.
IDPC assesses the state of play in global drug policy, reflecting on areas of progress while highlighting new and ongoing challenges, and concluding with recommendations for the future of international drug policy.
As the United Nations embarks on far-reaching institutional reform, a major new report from the International Drug Policy Consortium (IDPC) delivers a stark warning: global drug control is failing.
As drug policy reform faces renewed repression and securitisation worldwide, 2026 will test whether evidence, human rights and community leadership can still reshape a system under strain — and where the next openings for change may emerge.
Deep budget cuts to the UN’s human rights pillar will severely weaken the organisation’s ability to prevent abuses, protect defenders and support human rights.
EHRA provide a comparative assessment of harm reduction across Southeastern Europe, positioning political commitment and financing as critical to closing gaps.
The European Commission's new Drug Strategy promotes a worrying security-driven 'drug threat' narrative that fails to prioritise health and human rights over punishment.
